214 related articles for article (PubMed ID: 11476119)
21. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
[TBL] [Abstract][Full Text] [Related]
22. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
23. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial.
Segal J; Berk M; Brook S
Clin Neuropharmacol; 1998; 21(3):176-80. PubMed ID: 9617509
[TBL] [Abstract][Full Text] [Related]
24. Acute and continuation risperidone monotherapy in mania.
Vieta E; Brugué E; Goikolea JM; Sánchez-Moreno J; Reinares M; Comes M; Colom F; Martínez-Arán A; Benabarre A; Torrent C
Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711
[TBL] [Abstract][Full Text] [Related]
25. Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial.
Heck AH; Haffmans PM; de Groot IW; Hoencamp E
Schizophr Res; 2000 Dec; 46(2-3):97-105. PubMed ID: 11120421
[TBL] [Abstract][Full Text] [Related]
26. An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.
Hirschfeld RM; Eerdekens M; Kalali AH; Canuso CM; Khan AA; Karcher K; Palumbo JM
Int Clin Psychopharmacol; 2006 Jan; 21(1):11-20. PubMed ID: 16317312
[TBL] [Abstract][Full Text] [Related]
27. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
28. Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain.
Vieta E; Herraiz M; Parramon G; Goikolea JM; Fernández A; Benabarre A
J Affect Disord; 2002 Oct; 72(1):15-9. PubMed ID: 12204313
[TBL] [Abstract][Full Text] [Related]
29. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.
Conley RR; Mahmoud R
Am J Psychiatry; 2001 May; 158(5):765-74. PubMed ID: 11329400
[TBL] [Abstract][Full Text] [Related]
30. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
[TBL] [Abstract][Full Text] [Related]
31. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study.
Khanna S; Vieta E; Lyons B; Grossman F; Eerdekens M; Kramer M
Br J Psychiatry; 2005 Sep; 187():229-34. PubMed ID: 16135859
[TBL] [Abstract][Full Text] [Related]
32. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
33. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
[TBL] [Abstract][Full Text] [Related]
34. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
[TBL] [Abstract][Full Text] [Related]
36. Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.
Tohen M; Zhang F; Keck PE; Feldman PD; Risser RC; Tran PV; Breier A
J Affect Disord; 2001 Dec; 67(1-3):133-40. PubMed ID: 11869760
[TBL] [Abstract][Full Text] [Related]
37. Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Int Clin Psychopharmacol; 2001 Nov; 16(6):325-30. PubMed ID: 11712620
[TBL] [Abstract][Full Text] [Related]
38. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
[TBL] [Abstract][Full Text] [Related]
39. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
Tohen M; Goldberg JF; Gonzalez-Pinto Arrillaga AM; Azorin JM; Vieta E; Hardy-Bayle MC; Lawson WB; Emsley RA; Zhang F; Baker RW; Risser RC; Namjoshi MA; Evans AR; Breier A
Arch Gen Psychiatry; 2003 Dec; 60(12):1218-26. PubMed ID: 14662554
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.
Blin O; Azorin JM; Bouhours P
J Clin Psychopharmacol; 1996 Feb; 16(1):38-44. PubMed ID: 8834417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
